Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.
Eli Lilly's Orforglipron Beats Novo Nordisk's GLP-1 Pill in Tests
Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.
Last updated: April 4, 2026, 5:16 AM
Related Stories
Business16h ago
Senate Gridlock Delays Kevin Warsh Confirmation as Fed Chair Amid Economic Uncertainty
Kevin Warsh's nomination to lead the Federal Reserve remains stalled in the Senate, threatening economic stability as inflation looms and global conflicts raise concerns. With Jerome Powell's term nearing its end and President Trump pushing for a replacement, the delay risks leaving the central bank
Business18h ago
St. Louis Marketing CEO Kasey Grelle Killed in Nicaragua Tour Bus Crash, Son Critically Injured
Kasey Grelle, 41, co-founder of St. Louis marketing firm Aux Insights, died in a Nicaragua tour bus crash March 23 while on family vacation. Her 11-year-old son Julian suffered critical injuries, and the family has raised over $300,000 in support.
Business22h ago
Trump's Dual Strategy: Military Buildup in Middle East as Iran Conflict Nears Crucial Mid-April Inflection Point
President Donald Trump is rapidly escalating U.S. military presence in the Middle East, deploying thousands of troops and multiple aircraft carriers, while sending mixed signals on Iran negotiations. Analysts warn of a mid-April decision point as Iran's control over the Strait of Hormuz and residual